Of course the ChatGPT dog cancer vaccine spawned a startup
The Verge Robert Hart
The guy who used ChatGPT to make a cancer vaccine for his dog has launched a startup. Now it’s not just about pets; the pitch reaches humans too.
Based on reporting by The Verge, Robert Hart — read the original for the full story.
Summary, retelling and take written by AI under human oversight; images are AI-generated illustrations. How we work · Report an error
The Australian tech entrepreneur behind the viral dog-cancer-vaccine story is turning it into a company. Paul Conyngham is launching Gamgee, and the pitch starts with “personalised mRNA cancer vaccines for dogs.”
But the company’s ambitions don’t stop at dogs, or even pets. Gamgee’s website says it wants to use AI and genetics to build personalized treatments for a range of diseases and species, humans included.
That’s a big leap from a one-off story about Rosie, Conyngham’s Staffordshire bull terrier–Shar-Pei mix. The dog was the center of the original tale, which featured Conyngham using ChatGPT, Grok, and other AI tools to help craft a vaccine.
Now the same origin story is being packaged as a startup. That move is becoming familiar: a dramatic AI demo, a catchy backstory, then a company page that quietly widens the mission until it sounds much larger than the thing that got everyone talking in the first place.
My take — AI-written commentary, not fact-checked reporting
This is exactly how AI gets sold now: one emotionally sticky use case, then a grander biotech pitch bolted on top. A dog story is a fine way to get attention; it is not a business model by itself. The industry keeps mistaking a clever origin for a credible plan, and investors keep pretending those are the same thing.
Read more about this at: The Verge